A detailed history of Exodus Point Capital Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 139,889 shares of BMY stock, worth $8.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
139,889
Holding current value
$8.08 Million
% of portfolio
0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $5.55 Million - $7.24 Million
139,889 New
139,889 $7.24 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $9.48 Million - $10.6 Million
-163,721 Reduced 73.71%
58,397 $3.39 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $24.3 Million - $27 Million
-381,907 Reduced 63.23%
222,118 $14.2 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $24.8 Million - $28.1 Million
377,684 Added 166.87%
604,025 $41.9 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $15.5 Million - $18.4 Million
226,341 New
226,341 $16.3 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $12.6 Million - $14.6 Million
-234,125 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $11.8 Million - $13.8 Million
199,709 Added 580.28%
234,125 $13.9 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $161,832 - $176,235
2,614 Added 8.22%
34,416 $2.3 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $2.24 Million - $2.52 Million
-37,719 Reduced 54.26%
31,802 $2.01 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $4.01 Million - $4.55 Million
69,521 New
69,521 $4.31 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $16 Million - $17.7 Million
-278,398 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $9.42 Million - $11 Million
171,879 Added 161.36%
278,398 $16.4 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $4.94 Million - $7.18 Million
106,519 New
106,519 $5.94 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $3.03 Million - $3.95 Million
-61,528 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $588,771 - $698,073
-13,766 Reduced 18.28%
61,528 $3.12 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $3.09 Million - $3.69 Million
68,562 Added 1018.45%
75,294 $3.59 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $328,252 - $425,664
6,732 New
6,732 $350,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.